Incidence rate and malignancy risk in new nodules in a lung cancer screening programme

Question What is the incidence and malignancy risk of new nodules appearing at annual and nodule follow-up interval CTs in lung cancer screening? Findings New nodules were seen in 11.1% and 8.4% of participants at annual low-dose CT and 3-month interval CT, respectively. Malignancy risk at annual CT increased with nodule size. Clinical relevance In a lung cancer screening programme, new nodules at annual and nodule follow-up CTs occur in around 1 in 10 participants. Lower size thresholds for further surveillance or definitive investigation should be considered compared to nodules at baseline CT.

Authors

Institutions

Publication Details

Journal
European Radiology
Published
2025-04-24
DOI
https://doi.org/10.1007/s00330-025-11576-3
Citations
1
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidence rate and malignancy risk in new nodules in a lung cancer screening programme

Amyn Bhamani, Allan Hackshaw, Priyam Verghese, Carolyn Horst et al.
1 citations
European Radiology
Lung Cancer Diagnosis and Treatment
1.52
article

Incidence rate and malignancy risk in new nodules in a lung cancer screening programme

Amyn Bhamani, Allan Hackshaw, Priyam Verghese, Carolyn Horst, Sophie Tisi, Jennifer Dickson, Chuen Ryan Khaw, Kylie Gyertson, Laura Farrelly, Sam M. Janes, Andrew Creamer, Helen Hall, Arjun Nair, Ruth Prendecki, Anne-Marie Hacker, John McCabe, Anand Devaraj
article en
1 citations

Abstract

Question What is the incidence and malignancy risk of new nodules appearing at annual and nodule follow-up interval CTs in lung cancer screening? Findings New nodules were seen in 11.1% and 8.4% of participants at annual low-dose CT and 3-month interval CT, respectively. Malignancy risk at annual CT increased with nodule size. Clinical relevance In a lung cancer screening programme, new nodules at annual and nodule follow-up CTs occur in around 1 in 10 participants. Lower size thresholds for further surveillance or definitive investigation should be considered compared to nodules at baseline CT.

European RadiologyVol. 35(11)
Barking, Havering And Redbridge University Hospitals NHS Trust (GB), North Bristol NHS Trust (GB), University College London Hospitals NHS Foundation Trust (GB), Queen Mary University of London (GB), Royal Free London NHS Foundation Trust (GB), Barts Health NHS Trust (GB), Royal Brompton & Harefield NHS Foundation Trust (GB), Anthony Nolan (GB), Princess Alexandra Hospital NHS Trust (GB), Cancer Research UK (GB), Papworth Hospital NHS Foundation Trust (GB), King's College Hospital NHS Foundation Trust (GB), Homerton University Hospital NHS Foundation Trust (GB), London Borough of Tower Hamlets (GB), Imagerie Médicale et Radiothérapie Drôme Ardèche (FR), Whittington Health NHS Trust (GB), The London College (GB), North Middlesex University Hospital NHS Trust (GB), University Hospitals Sussex NHS Foundation Trust (GB), Surrey and Sussex Healthcare NHS Trust (GB), Royal United Hospital Bath NHS Trust (GB), University College London (GB), Imperial College London (GB)
Roy Castle Lung Cancer Foundation, Wellcome Trust, UCL Hospitals Charitable Foundation, Cancer Research UK, Rosetrees Trust, University College London Hospitals NHS Foundation Trust
Good health and well-being
Openalex Percentile: Top 18%
Lung Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.